Latest Period
Q1 2026
Security Snapshot
LifeStance Health Group, Inc. - Common Stock, par value $0.01 per share (LFST) Institutional Ownership
CUSIP: 53228F101
13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026
Institutions Reporting
226
Shares (Excl. Options)
368,584,823
Price
$6.37
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Symbol
- LFST on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 368,584,823
- Total 13F value
- $2,348,160,165
- Portfolio coverage rank
- 0.02%
- Share change
- -6,275,197
- Value change
- -$41,030,315
- Number of holders
- 226
- Shares outstanding
- 381,380,935
- SEC-reported price per share
- $7.70
- Insider filing price
- $7.70
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- LFST - LifeStance Health Group, Inc. - Common Stock, par value $0.01 per share is tracked under CUSIP 53228F101.
- 226 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 204 to 226 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $2,631,720,829 to $2,348,160,165.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 226 institutions filings for Q1 2026.
Security key
53228F101
Latest holder period
Q1 2026
13F holders
226
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
LFST full holder history
LifeStance Health Group, Inc. SEC filings
LifeStance Health Group, Inc. company facts
LifeStance Health Group, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 53228F101:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
LFST
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| TPG GP A, LLC | 29% | $711,813,191 | 111,744,614 | TPG GP A, LLC | 31 Mar 2026 | |||
| FMR LLC | 15% | +25% | $372,437,846 | +$74,915,634 | 58,467,480 | +25% | FMR LLC | 31 Mar 2026 |
| SUMMIT PARTNERS L P | 7.5% | -13% | $186,066,273 | -$27,486,161 | 29,209,776 | -13% | Summit Partners, L.P. | 31 Mar 2026 |
As of 31 Mar 2026, 226 institutional investors reported holding 368,584,823 shares of LifeStance Health Group, Inc. - Common Stock, par value $0.01 per share (LFST). This represents 97% of the company’s total 381,380,935 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
89%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| TPG GP A, LLC | 37% | 140,026,557 | -13% | 24% | $891,969,168 |
| FMR LLC | 15% | 58,685,480 | +25% | 0.02% | $373,826,506 |
| SUMMIT PARTNERS L P | 7.7% | 29,209,776 | -13% | 28% | $186,066,273 |
| BlackRock, Inc. | 4.8% | 18,134,951 | -5% | 0% | $115,519,637 |
| DIMENSIONAL FUND ADVISORS LP | 2.7% | 10,367,680 | +16% | 0.01% | $66,037,902 |
| JENNISON ASSOCIATES LLC | 2.7% | 10,228,801 | +39% | 0.04% | $65,157,464 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.5% | 9,682,305 | 0% | 0% | $61,676,283 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.1% | 7,908,159 | 0% | 0% | $50,374,973 |
| Silversmith Partners I GP, LLC | 1.6% | 6,157,127 | -57% | 100% | $39,220,899 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.6% | 6,092,223 | -0.42% | 0.01% | $38,807,460 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2% | 4,725,154 | +7.9% | 0% | $30,105,345 |
| Integral Health Asset Management, LLC | 1.1% | 4,300,000 | +43% | 1.4% | $27,391,000 |
| STATE STREET CORP | 1.1% | 4,093,494 | +12% | 0% | $26,075,557 |
| CITADEL ADVISORS LLC | 1% | 3,850,026 | +9568% | 0.02% | $24,524,666 |
| MORGAN STANLEY | 0.9% | 3,441,226 | +4.1% | 0% | $21,920,612 |
| Qube Research & Technologies Ltd | 0.84% | 3,188,657 | +19% | 0.03% | $20,311,745 |
| PRINCIPAL FINANCIAL GROUP INC | 0.81% | 3,077,655 | -4.3% | 0.01% | $19,604,662 |
| BARCLAYS PLC | 0.73% | 2,765,692 | -20% | 0.01% | $17,617,458 |
| Nuveen, LLC | 0.58% | 2,210,932 | -24% | 0% | $14,083,637 |
| GOLDMAN SACHS GROUP INC | 0.55% | 2,086,443 | -37% | 0% | $13,290,641 |
| BANK OF AMERICA CORP /DE/ | 0.52% | 1,994,027 | +165% | 0% | $12,701,953 |
| MILLENNIUM MANAGEMENT LLC | 0.5% | 1,899,049 | +11% | 0.01% | $12,096,942 |
| Woodline Partners LP | 0.48% | 1,815,221 | +88% | 0.04% | $11,562,958 |
| LOOMIS SAYLES & CO L P | 0.44% | 1,682,331 | -2.5% | 0.01% | $10,716,448 |
| First Eagle Investment Management, LLC | 0.42% | 1,610,466 | +7.6% | 0.02% | $10,258,668 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
20
Latest
Q1 2026
Rows shown
1-20 of 20
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 368,584,823 | $2,348,160,165 | -$41,030,315 | $6.37 | 226 |
| 2025 Q4 | 373,840,439 | $2,631,720,829 | +$79,141,014 | $7.04 | 204 |
| 2025 Q3 | 349,969,140 | $1,924,816,649 | +$2,242,263 | $5.50 | 208 |
| 2025 Q2 | 349,211,507 | $1,805,446,226 | +$26,470,202 | $5.17 | 193 |
| 2025 Q1 | 343,293,098 | $2,286,399,131 | +$28,506,338 | $6.66 | 180 |
| 2024 Q4 | 336,632,306 | $2,481,009,214 | +$57,920,008 | $7.37 | 152 |
| 2024 Q3 | 328,987,104 | $2,302,787,638 | +$385,503 | $7.00 | 129 |
| 2024 Q2 | 327,111,787 | $1,606,123,781 | +$26,316,859 | $4.91 | 130 |
| 2024 Q1 | 321,255,679 | $1,982,331,016 | +$72,312,533 | $6.17 | 123 |
| 2023 Q4 | 309,497,893 | $2,423,368,969 | +$91,163,728 | $7.83 | 118 |
| 2023 Q3 | 298,420,193 | $2,050,146,379 | +$48,948,530 | $6.87 | 117 |
| 2023 Q2 | 290,988,403 | $2,656,744,574 | +$31,775,791 | $9.13 | 109 |
| 2023 Q1 | 287,568,675 | $2,136,617,078 | +$2,802,644 | $7.43 | 86 |
| 2022 Q4 | 287,897,858 | $1,422,185,198 | -$5,682,633 | $4.94 | 84 |
| 2022 Q3 | 288,807,286 | $1,911,997,521 | -$30,576,662 | $6.62 | 72 |
| 2022 Q2 | 294,731,958 | $1,638,707,002 | +$20,710,430 | $5.56 | 76 |
| 2022 Q1 | 290,691,955 | $2,938,605,431 | +$156,460,286 | $10.11 | 72 |
| 2021 Q4 | 275,145,168 | $2,619,339,115 | -$24,317,438 | $9.52 | 62 |
| 2021 Q3 | 275,121,437 | $3,989,223,790 | -$38,569,110 | $14.50 | 68 |
| 2021 Q2 | 270,204,603 | $7,528,083,656 | +$7,528,083,616 | $27.86 | 81 |